The utilization of livers from uncontrolled donor circulatory death (uDCD) donation increases the availability of liver grafts, but is associated with a higher incidence of biliary complications (BCs) and lower graft survival than those donated after brain death (DBD). From January 2006 to December 2016, we performed 75 orthotopic liver transplantations (OLT) using uDCD livers. To investigate the relationship of BCs with the use of uDCD OLT, we compared patients who developed BCs (23 cases) to those who did not (non‐BC, 43 cases) after excluding cases of primary nonfunction and hepatic artery thrombosis, a known cause of BC. The groups had similar uDCD donor maintenance, donor and recipient characteristics, and perioperative morbidity/mortality rates, but we observed a higher rate of hepatocellular carcinoma and hepatitis C virus in the non‐BC group. For BC management, percutaneous transhepatic biliary dilation was performed in 21 cases, endoscopic retrograde cholangiopancreatography dilation in 3 cases, Roux‐en‐Y hepaticojejunostomy in 6 cases, T‐tube in 1 case, and retransplantation in 3 cases. In the BC group, 1‐, 3‐, and 5‐year patient survival was 91.3%, 69.6%, and 65.2% versus 77.8%, 72.9%, and 72.9% in the non‐BC group (P=0.89), whereas 1‐, 3‐, and 5‐year graft survival was 78.3%, 60.9%, and 56.5% in BC group versus 77.8%, 72.9%, and 72.9% in the non‐BC group (P=0.38). Multivariate analysis did not indicate independent risk factors for BC development. Conclusion: Patient and graft survival was generally lower in patients who developed BCs, but not significantly so, and these complications were managed in the majority of patients through radiological, endoscopical, or Roux‐en‐Y hepaticojejunostomy. Retransplantation is necessary in rare cases, after the failure of biliary dilation or surgical procedures.